|
1
|
Prevalence of chronic kidney disease in the United States.
|
JAMA
|
2007
|
38.98
|
|
2
|
Assessing kidney function--measured and estimated glomerular filtration rate.
|
N Engl J Med
|
2006
|
20.27
|
|
3
|
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis.
|
Lancet
|
2010
|
18.36
|
|
4
|
Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.
|
Circulation
|
2003
|
15.79
|
|
5
|
Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD.
|
Am J Kidney Dis
|
2008
|
15.04
|
|
6
|
Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey.
|
Am J Kidney Dis
|
2003
|
15.00
|
|
7
|
Estimating glomerular filtration rate from serum creatinine and cystatin C.
|
N Engl J Med
|
2012
|
14.99
|
|
8
|
A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.
|
N Engl J Med
|
2009
|
14.13
|
|
9
|
Effect of dialysis dose and membrane flux in maintenance hemodialysis.
|
N Engl J Med
|
2002
|
10.52
|
|
10
|
Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program.
|
Clin Chem
|
2005
|
8.93
|
|
11
|
Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study.
|
Lancet Oncol
|
2006
|
8.61
|
|
12
|
Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies.
|
J Am Soc Nephrol
|
2004
|
8.21
|
|
13
|
Cystatin C versus creatinine in determining risk based on kidney function.
|
N Engl J Med
|
2013
|
7.98
|
|
14
|
Calibration of serum creatinine in the National Health and Nutrition Examination Surveys (NHANES) 1988-1994, 1999-2004.
|
Am J Kidney Dis
|
2007
|
7.86
|
|
15
|
Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate.
|
Am J Kidney Dis
|
2002
|
7.03
|
|
16
|
Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate.
|
JAMA
|
2012
|
6.26
|
|
17
|
Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts.
|
Kidney Int
|
2011
|
6.01
|
|
18
|
Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.
|
Hypertension
|
2003
|
6.01
|
|
19
|
Evaluation of the modification of diet in renal disease study equation in a large diverse population.
|
J Am Soc Nephrol
|
2007
|
6.00
|
|
20
|
Factors other than glomerular filtration rate affect serum cystatin C levels.
|
Kidney Int
|
2008
|
5.90
|
|
21
|
Partial nephrectomy versus radical nephrectomy in patients with small renal tumors--is there a difference in mortality and cardiovascular outcomes?
|
J Urol
|
2008
|
5.70
|
|
22
|
Erythropoietic response and outcomes in kidney disease and type 2 diabetes.
|
N Engl J Med
|
2010
|
5.48
|
|
23
|
Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis.
|
Ann Intern Med
|
2003
|
5.47
|
|
24
|
Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts.
|
Kidney Int
|
2011
|
5.47
|
|
25
|
The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study.
|
Ann Intern Med
|
2005
|
5.45
|
|
26
|
The timing of specialist evaluation in chronic kidney disease and mortality.
|
Ann Intern Med
|
2002
|
5.33
|
|
27
|
Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts.
|
Kidney Int
|
2011
|
5.25
|
|
28
|
Impact of creatinine calibration on performance of GFR estimating equations in a pooled individual patient database.
|
Am J Kidney Dis
|
2007
|
5.06
|
|
29
|
Kidney-Failure Risk Projection for the Living Kidney-Donor Candidate.
|
N Engl J Med
|
2015
|
5.03
|
|
30
|
Comparison of drug dosing recommendations based on measured GFR and kidney function estimating equations.
|
Am J Kidney Dis
|
2009
|
4.30
|
|
31
|
A predictive model for progression of chronic kidney disease to kidney failure.
|
JAMA
|
2011
|
4.22
|
|
32
|
Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/min/1.73 m2.
|
Am J Kidney Dis
|
2010
|
3.87
|
|
33
|
Cystatin C identifies chronic kidney disease patients at higher risk for complications.
|
J Am Soc Nephrol
|
2010
|
3.85
|
|
34
|
Patient awareness of chronic kidney disease: trends and predictors.
|
Arch Intern Med
|
2008
|
3.72
|
|
35
|
Testing for chronic kidney disease: a position statement from the National Kidney Foundation.
|
Am J Kidney Dis
|
2007
|
3.53
|
|
36
|
Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community.
|
J Am Coll Cardiol
|
2003
|
3.48
|
|
37
|
Estimation of glomerular filtration rates before and after orthotopic liver transplantation: evaluation of current equations.
|
Liver Transpl
|
2004
|
3.46
|
|
38
|
Chronic kidney disease is common: what do we do next?
|
Nephrol Dial Transplant
|
2008
|
3.41
|
|
39
|
Effect of a very low-protein diet on outcomes: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study.
|
Am J Kidney Dis
|
2008
|
3.34
|
|
40
|
Evolving importance of kidney disease: from subspecialty to global health burden.
|
Lancet
|
2013
|
3.30
|
|
41
|
National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification.
|
Pediatrics
|
2003
|
3.10
|
|
42
|
Method of glomerular filtration rate estimation affects prediction of mortality risk.
|
J Am Soc Nephrol
|
2009
|
3.05
|
|
43
|
Measured GFR as a confirmatory test for estimated GFR.
|
J Am Soc Nephrol
|
2009
|
3.00
|
|
44
|
Expressing the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) cystatin C equations for estimating GFR with standardized serum cystatin C values.
|
Am J Kidney Dis
|
2011
|
2.98
|
|
45
|
Uric acid and long-term outcomes in CKD.
|
Am J Kidney Dis
|
2009
|
2.86
|
|
46
|
Imprecision of urinary iothalamate clearance as a gold-standard measure of GFR decreases the diagnostic accuracy of kidney function estimating equations.
|
Am J Kidney Dis
|
2010
|
2.83
|
|
47
|
Comparing the risk for death with peritoneal dialysis and hemodialysis in a national cohort of patients with chronic kidney disease.
|
Ann Intern Med
|
2005
|
2.82
|
|
48
|
Level of kidney function as a risk factor for cardiovascular outcomes in the elderly.
|
Kidney Int
|
2003
|
2.77
|
|
49
|
Cystatin C as a risk factor for outcomes in chronic kidney disease.
|
Ann Intern Med
|
2007
|
2.71
|
|
50
|
Estimating equations for glomerular filtration rate in the era of creatinine standardization: a systematic review.
|
Ann Intern Med
|
2012
|
2.69
|
|
51
|
Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK).
|
Am J Kidney Dis
|
2003
|
2.68
|
|
52
|
Cardiovascular disease and subsequent kidney disease.
|
Arch Intern Med
|
2007
|
2.65
|
|
53
|
Serum cystatin C in the United States: the Third National Health and Nutrition Examination Survey (NHANES III).
|
Am J Kidney Dis
|
2008
|
2.64
|
|
54
|
Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients: primary results from the Folic Acid for Vascular Outcome Reduction in Transplantation trial.
|
Circulation
|
2011
|
2.62
|
|
55
|
Clinical practice guidelines in nephrology--for worse or for better.
|
Nephrol Dial Transplant
|
2006
|
2.58
|
|
56
|
Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study.
|
J Am Soc Nephrol
|
2002
|
2.58
|
|
57
|
Uric acid and incident kidney disease in the community.
|
J Am Soc Nephrol
|
2008
|
2.44
|
|
58
|
Estimating GFR using the CKD Epidemiology Collaboration (CKD-EPI) creatinine equation: more accurate GFR estimates, lower CKD prevalence estimates, and better risk predictions.
|
Am J Kidney Dis
|
2010
|
2.41
|
|
59
|
Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study.
|
Kidney Int
|
2004
|
2.38
|
|
60
|
Association between body mass index and CKD in apparently healthy men.
|
Am J Kidney Dis
|
2005
|
2.30
|
|
61
|
Clinical practice guidelines for chronic kidney disease in adults: Part I. Definition, disease stages, evaluation, treatment, and risk factors.
|
Am Fam Physician
|
2004
|
2.27
|
|
62
|
Anemia as a risk factor for cardiovascular disease in The Atherosclerosis Risk in Communities (ARIC) study.
|
J Am Coll Cardiol
|
2002
|
2.25
|
|
63
|
Associations of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: a meta-analysis.
|
BMJ
|
2013
|
2.24
|
|
64
|
Pro: Estimating GFR using the chronic kidney disease epidemiology collaboration (CKD-EPI) 2009 creatinine equation: the time for change is now.
|
Nephrol Dial Transplant
|
2013
|
2.20
|
|
65
|
Cardiovascular outcomes and all-cause mortality: exploring the interaction between CKD and cardiovascular disease.
|
Am J Kidney Dis
|
2006
|
2.16
|
|
66
|
C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease.
|
Kidney Int
|
2005
|
2.13
|
|
67
|
Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study.
|
J Am Soc Nephrol
|
2005
|
2.07
|
|
68
|
Association between cardiac biomarkers and the development of ESRD in patients with type 2 diabetes mellitus, anemia, and CKD.
|
Am J Kidney Dis
|
2011
|
2.05
|
|
69
|
Progression risk, urinary protein excretion, and treatment effects of angiotensin-converting enzyme inhibitors in nondiabetic kidney disease.
|
J Am Soc Nephrol
|
2007
|
2.00
|
|
70
|
The Framingham predictive instrument in chronic kidney disease.
|
J Am Coll Cardiol
|
2007
|
2.00
|
|
71
|
Low rates of testing and diagnostic codes usage in a commercial clinical laboratory: evidence for lack of physician awareness of chronic kidney disease.
|
J Am Soc Nephrol
|
2005
|
1.98
|
|
72
|
Frequency of patient-physician contact and patient outcomes in hemodialysis care.
|
J Am Soc Nephrol
|
2004
|
1.97
|
|
73
|
Ethnic subgroup differences in hypertension in Pakistan.
|
J Hypertens
|
2003
|
1.94
|
|
74
|
CKD in the elderly--old questions and new challenges: World Kidney Day 2008.
|
Am J Kidney Dis
|
2008
|
1.93
|
|
75
|
Waist-to-hip ratio, body mass index, and subsequent kidney disease and death.
|
Am J Kidney Dis
|
2008
|
1.92
|
|
76
|
Albuminuria, cognitive functioning, and white matter hyperintensities in homebound elders.
|
Am J Kidney Dis
|
2008
|
1.91
|
|
77
|
Use of albumin creatinine ratio and urine albumin concentration as a screening test for albuminuria in an Indo-Asian population.
|
Nephrol Dial Transplant
|
2007
|
1.91
|
|
78
|
Changes in dietary protein intake has no effect on serum cystatin C levels independent of the glomerular filtration rate.
|
Kidney Int
|
2010
|
1.88
|
|
79
|
Kidney disease as a risk factor for recurrent cardiovascular disease and mortality.
|
Am J Kidney Dis
|
2004
|
1.88
|
|
80
|
Waist-to-hip ratio and body mass index as risk factors for cardiovascular events in CKD.
|
Am J Kidney Dis
|
2008
|
1.82
|
|
81
|
Evaluation of the Chronic Kidney Disease Epidemiology Collaboration equation for estimating the glomerular filtration rate in multiple ethnicities.
|
Kidney Int
|
2010
|
1.81
|
|
82
|
Chronic kidney disease in the elderly--how to assess risk.
|
N Engl J Med
|
2005
|
1.81
|
|
83
|
Agreement of self-reported comorbid conditions with medical and physician reports varied by disease among end-stage renal disease patients.
|
J Clin Epidemiol
|
2006
|
1.79
|
|
84
|
Serum creatinine as marker of kidney function in South Asians: a study of reduced GFR in adults in Pakistan.
|
J Am Soc Nephrol
|
2005
|
1.76
|
|
85
|
Prognostic assessment of estimated glomerular filtration rate by the new Chronic Kidney Disease Epidemiology Collaboration equation in comparison with the Modification of Diet in Renal Disease Study equation.
|
Am Heart J
|
2011
|
1.71
|
|
86
|
Adiponectin and mortality in patients with chronic kidney disease.
|
J Am Soc Nephrol
|
2006
|
1.70
|
|
87
|
Body mass index and mortality in CKD.
|
Am J Kidney Dis
|
2007
|
1.68
|
|
88
|
Anemia as a risk factor for cardiovascular disease and all-cause mortality in diabetes: the impact of chronic kidney disease.
|
J Am Soc Nephrol
|
2005
|
1.68
|
|
89
|
Measurement of kidney function.
|
Med Clin North Am
|
2005
|
1.65
|
|
90
|
Equations to estimate creatinine excretion rate: the CKD epidemiology collaboration.
|
Clin J Am Soc Nephrol
|
2010
|
1.65
|
|
91
|
Obesity, glomerular hyperfiltration, and the surface area correction.
|
Am J Kidney Dis
|
2010
|
1.64
|
|
92
|
Comparison of causes of death using HEMO Study and HCFA end-stage renal disease death notification classification systems. The National Institutes of Health-funded Hemodialysis. Health Care Financing Administration.
|
Am J Kidney Dis
|
2002
|
1.63
|
|
93
|
Variation in the serum creatinine assay calibration: a practical application to glomerular filtration rate estimation.
|
Kidney Int
|
2005
|
1.62
|
|
94
|
Relationship between homocysteine and mortality in chronic kidney disease.
|
Circulation
|
2006
|
1.58
|
|
95
|
Comorbidity and other factors associated with modality selection in incident dialysis patients: the CHOICE Study. Choices for Healthy Outcomes in Caring for End-Stage Renal Disease.
|
Am J Kidney Dis
|
2002
|
1.56
|
|
96
|
Effects of high-flux hemodialysis on clinical outcomes: results of the HEMO study.
|
J Am Soc Nephrol
|
2003
|
1.56
|
|
97
|
Both low muscle mass and low fat are associated with higher all-cause mortality in hemodialysis patients.
|
Kidney Int
|
2010
|
1.55
|
|
98
|
Trends in the prevalence of reduced GFR in the United States: a comparison of creatinine- and cystatin C-based estimates.
|
Am J Kidney Dis
|
2013
|
1.54
|
|
99
|
The relationship between nontraditional risk factors and outcomes in individuals with stage 3 to 4 CKD.
|
Am J Kidney Dis
|
2008
|
1.53
|
|
100
|
Clinical practice guidelines in nephrology: evaluation, classification, and stratification of chronic kidney disease.
|
Pharmacotherapy
|
2005
|
1.52
|
|
101
|
General practitioners' approach to hypertension in urban Pakistan: disturbing trends in practice.
|
Circulation
|
2005
|
1.51
|
|
102
|
Advances in glomerular filtration rate-estimating equations.
|
Curr Opin Nephrol Hypertens
|
2010
|
1.49
|
|
103
|
Relationship of phosphorus and calcium-phosphorus product with mortality in CKD.
|
Am J Kidney Dis
|
2005
|
1.49
|
|
104
|
Predicting 1 year mortality in an outpatient haemodialysis population: a comparison of comorbidity instruments.
|
Nephrol Dial Transplant
|
2004
|
1.46
|
|
105
|
Development and validation of GFR-estimating equations using diabetes, transplant and weight.
|
Nephrol Dial Transplant
|
2009
|
1.46
|
|
106
|
Disordered mineral metabolism in hemodialysis patients: an analysis of cumulative effects in the Hemodialysis (HEMO) Study.
|
Am J Kidney Dis
|
2008
|
1.46
|
|
107
|
Comorbidity and its change predict survival in incident dialysis patients.
|
Am J Kidney Dis
|
2003
|
1.45
|
|
108
|
Dialysis facility ownership and epoetin dosing in hemodialysis patients: an overview.
|
Am J Kidney Dis
|
2007
|
1.44
|
|
109
|
Filtration markers may have prognostic value independent of glomerular filtration rate.
|
J Am Soc Nephrol
|
2011
|
1.43
|
|
110
|
Estimating the prevalence of low glomerular filtration rate requires attention to the creatinine assay calibration.
|
J Am Soc Nephrol
|
2002
|
1.43
|
|
111
|
Surrogate end points for clinical trials of kidney disease progression.
|
Clin J Am Soc Nephrol
|
2006
|
1.42
|
|
112
|
Relationship between C-reactive protein, albumin, and cardiovascular disease in patients with chronic kidney disease.
|
Am J Kidney Dis
|
2003
|
1.42
|
|
113
|
Performance of creatinine and cystatin C GFR estimating equations in an HIV-positive population on antiretrovirals.
|
J Acquir Immune Defic Syndr
|
2012
|
1.38
|
|
114
|
Risk prediction models for patients with chronic kidney disease: a systematic review.
|
Ann Intern Med
|
2013
|
1.33
|
|
115
|
Resistance training to reduce the malnutrition-inflammation complex syndrome of chronic kidney disease.
|
Am J Kidney Dis
|
2004
|
1.32
|
|
116
|
Key comorbid conditions that are predictive of survival among hemodialysis patients.
|
Clin J Am Soc Nephrol
|
2009
|
1.32
|
|
117
|
The rate of progression of renal disease may not be slower in women compared with men: a patient-level meta-analysis.
|
Nephrol Dial Transplant
|
2003
|
1.30
|
|
118
|
High lipoprotein(a) levels and small apolipoprotein(a) size prospectively predict cardiovascular events in dialysis patients.
|
J Am Soc Nephrol
|
2005
|
1.29
|
|
119
|
A comparison of change in measured and estimated glomerular filtration rate in patients with nondiabetic kidney disease.
|
Clin J Am Soc Nephrol
|
2008
|
1.29
|
|
120
|
Children in South Asia have higher body mass-adjusted blood pressure levels than white children in the United States: a comparative study.
|
Circulation
|
2005
|
1.28
|
|
121
|
Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney disease.
|
J Am Soc Nephrol
|
2005
|
1.28
|
|
122
|
Restless legs symptoms among incident dialysis patients: association with lower quality of life and shorter survival.
|
Am J Kidney Dis
|
2004
|
1.27
|
|
123
|
A framework and key research questions in AKI diagnosis and staging in different environments.
|
Clin J Am Soc Nephrol
|
2008
|
1.27
|
|
124
|
Cystatin C and creatinine in an HIV cohort: the nutrition for healthy living study.
|
Am J Kidney Dis
|
2008
|
1.25
|
|
125
|
Rationale--Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): evolving the management of cardiovascular risk in patients with chronic kidney disease.
|
Am Heart J
|
2005
|
1.25
|
|
126
|
Lowest systolic blood pressure is associated with stroke in stages 3 to 4 chronic kidney disease.
|
J Am Soc Nephrol
|
2007
|
1.25
|
|
127
|
Clinical risk implications of the CKD Epidemiology Collaboration (CKD-EPI) equation compared with the Modification of Diet in Renal Disease (MDRD) Study equation for estimated GFR.
|
Am J Kidney Dis
|
2012
|
1.22
|
|
128
|
Serum C-reactive protein and leptin as predictors of kidney disease progression in the Modification of Diet in Renal Disease Study.
|
Kidney Int
|
2002
|
1.20
|
|
129
|
Demographics and trends in overweight and obesity in patients at time of kidney transplantation.
|
Am J Kidney Dis
|
2003
|
1.17
|
|
130
|
Interferon treatment in hemodialysis patients with chronic hepatitis C virus infection: a systematic review of the literature and meta-analysis of treatment efficacy and harms.
|
Am J Kidney Dis
|
2008
|
1.17
|
|
131
|
Calibration of cystatin C in the National Health and Nutrition Examination Surveys (NHANES).
|
Am J Kidney Dis
|
2012
|
1.16
|
|
132
|
Cohort profile: the chronic kidney disease prognosis consortium.
|
Int J Epidemiol
|
2012
|
1.16
|
|
133
|
Con: Should we abandon the use of the MDRD equation in favour of the CKD-EPI equation?
|
Nephrol Dial Transplant
|
2013
|
1.15
|
|
134
|
Predictors of fatal and nonfatal cardiovascular events in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia: an analysis of the Trial to Reduce cardiovascular Events with Aranesp (darbepoetin-alfa) Therapy (TREAT).
|
Am Heart J
|
2011
|
1.15
|
|
135
|
Cerebrovascular disease in maintenance hemodialysis patients: results of the HEMO Study.
|
Am J Kidney Dis
|
2006
|
1.14
|
|
136
|
A systematic review finds prediction models for chronic kidney disease were poorly reported and often developed using inappropriate methods.
|
J Clin Epidemiol
|
2013
|
1.12
|
|
137
|
Early, intermediate, and long-term risk factors for mortality in incident dialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study.
|
Am J Kidney Dis
|
2007
|
1.12
|
|
138
|
Comparison of serum concentrations of β-trace protein, β2-microglobulin, cystatin C, and creatinine in the US population.
|
Clin J Am Soc Nephrol
|
2013
|
1.11
|
|
139
|
Within-person variability in kidney measures.
|
Am J Kidney Dis
|
2013
|
1.10
|
|
140
|
Frequency of sit-down patient care rounds, attainment of clinical performance targets, hospitalization, and mortality in hemodialysis patients.
|
J Am Soc Nephrol
|
2004
|
1.09
|
|
141
|
Rationale and design of the Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT) trial.
|
Am Heart J
|
2006
|
1.09
|
|
142
|
Current status and future perspectives for CKD testing.
|
Am J Kidney Dis
|
2009
|
1.09
|
|
143
|
Kidney disease, Framingham risk scores, and cardiac and mortality outcomes.
|
Am J Med
|
2007
|
1.08
|
|
144
|
Association between serum 2-microglobulin level and infectious mortality in hemodialysis patients.
|
Clin J Am Soc Nephrol
|
2007
|
1.07
|
|
145
|
The prevalence of reduced glomerular filtration rate in older hypertensive patients and its association with cardiovascular disease: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
|
Arch Intern Med
|
2004
|
1.06
|
|
146
|
Novel filtration markers as predictors of all-cause and cardiovascular mortality in US adults.
|
Am J Kidney Dis
|
2013
|
1.05
|
|
147
|
Baseline characteristics of participants in the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial.
|
Am J Kidney Dis
|
2008
|
1.03
|
|
148
|
Clinical implications of estimating equations for glomerular filtration rate.
|
Ann Intern Med
|
2004
|
1.02
|
|
149
|
The effect of angiotensin-converting-enzyme inhibitors on progression of advanced polycystic kidney disease.
|
Kidney Int
|
2005
|
1.02
|
|
150
|
Estimated GFR, albuminuria, and complications of chronic kidney disease.
|
J Am Soc Nephrol
|
2011
|
1.01
|
|
151
|
Effect of intra-dialytic, low-intensity strength training on functional capacity in adult haemodialysis patients: a randomized pilot trial.
|
Nephrol Dial Transplant
|
2010
|
1.01
|
|
152
|
How strong are patients' preferences in choices between dialysis modalities and doses?
|
Am J Kidney Dis
|
2004
|
1.00
|
|
153
|
Effect of dietary protein intake on serum total CO2 concentration in chronic kidney disease: Modification of Diet in Renal Disease study findings.
|
Clin J Am Soc Nephrol
|
2005
|
0.99
|
|
154
|
Clinical practice guidelines for chronic kidney disease in adults: Part II. Glomerular filtration rate, proteinuria, and other markers.
|
Am Fam Physician
|
2004
|
0.98
|
|
155
|
Ethnic differences and determinants of proteinuria among South Asian subgroups in Pakistan.
|
Kidney Int
|
2003
|
0.96
|
|
156
|
Baseline characteristics in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).
|
Am J Kidney Dis
|
2009
|
0.95
|
|
157
|
Glycosylated hemoglobin and mortality in patients with nondiabetic chronic kidney disease.
|
J Am Soc Nephrol
|
2005
|
0.95
|
|
158
|
Bias in assessment of health-related quality of life in a hemodialysis population: a comparison of self-administered and interviewer-administered surveys in the HEMO study.
|
J Am Soc Nephrol
|
2003
|
0.94
|
|
159
|
Definition and classification of kidney diseases.
|
Am J Kidney Dis
|
2013
|
0.94
|
|
160
|
Inflammation and inverse associations of body mass index and serum creatinine with mortality in hemodialysis patients.
|
J Ren Nutr
|
2007
|
0.93
|
|
161
|
Proteinuria in South Asian children: prevalence and determinants.
|
Pediatr Nephrol
|
2005
|
0.93
|
|
162
|
Level and determinants of kidney function in a South Asian population in Pakistan.
|
Am J Kidney Dis
|
2011
|
0.91
|
|
163
|
Serum β-trace protein and risk of mortality in incident hemodialysis patients.
|
Clin J Am Soc Nephrol
|
2012
|
0.91
|
|
164
|
High normal levels of albuminuria and risk of hypertension in Indo-Asian population.
|
Nephrol Dial Transplant
|
2011
|
0.91
|
|
165
|
CKD classification based on estimated GFR over three years and subsequent cardiac and mortality outcomes: a cohort study.
|
BMC Nephrol
|
2009
|
0.90
|
|
166
|
Accuracy of a GFR estimating equation over time in people with a wide range of kidney function.
|
Am J Kidney Dis
|
2012
|
0.89
|
|
167
|
Impact of reporting estimated glomerular filtration rate: it's not just about us.
|
Kidney Int
|
2009
|
0.87
|
|
168
|
Clinically unrecognized Q-wave myocardial infarction in patients with diabetes mellitus, systemic hypertension, and nephropathy.
|
Am J Cardiol
|
2004
|
0.86
|
|
169
|
Interferon for hepatitis C virus in hemodialysis--an individual patient meta-analysis of factors associated with sustained virological response.
|
Clin J Am Soc Nephrol
|
2009
|
0.85
|
|
170
|
Association of physical activity with mortality in chronic kidney disease.
|
J Nephrol
|
2008
|
0.85
|
|
171
|
Traditional cardiac risk factors in individuals with chronic kidney disease.
|
Semin Dial
|
2003
|
0.84
|
|
172
|
Classification of chronic kidney disease: a step forward.
|
Ann Intern Med
|
2011
|
0.84
|
|
173
|
Bardoxolone methyl, chronic kidney disease, and type 2 diabetes.
|
N Engl J Med
|
2011
|
0.84
|
|
174
|
Proteinuria among patients with chronic kidney disease: a performance measure for improving patient outcomes.
|
Jt Comm J Qual Patient Saf
|
2012
|
0.84
|
|
175
|
Early change in proteinuria as a surrogate outcome in kidney disease progression: a systematic review of previous analyses and creation of a patient-level pooled dataset.
|
Nephrol Dial Transplant
|
2010
|
0.83
|
|
176
|
Constructing a database of individual clinical trials for longitudinal analysis.
|
Control Clin Trials
|
2003
|
0.83
|
|
177
|
Long-term viral negativity after interferon for chronic hepatitis C virus infection in hemodialysis.
|
Clin J Am Soc Nephrol
|
2011
|
0.82
|
|
178
|
Estimating glomerular filtration rate using the chronic kidney disease-epidemiology collaboration creatinine equation: better risk predictions.
|
Circ Heart Fail
|
2012
|
0.82
|
|
179
|
Hyperhomocysteinemia in renal transplant recipients.
|
Am J Transplant
|
2002
|
0.82
|
|
180
|
Effect of protein restriction on serum and urine phosphate in the modification of diet in renal disease (MDRD) study.
|
Am J Kidney Dis
|
2013
|
0.82
|
|
181
|
Effect of angiotensin-converting enzyme inhibitors on progression of nondiabetic renal disease.
|
Ann Intern Med
|
2002
|
0.82
|
|
182
|
Clinical impact of reporting estimated glomerular filtration rates.
|
Clin Chem
|
2010
|
0.81
|
|
183
|
Developing guidelines for chronic kidney disease: we should include all of the outcomes.
|
Ann Intern Med
|
2012
|
0.81
|
|
184
|
The care of patients with chronic kidney disease.
|
J Gen Intern Med
|
2002
|
0.81
|
|
185
|
Homocysteine in chronic kidney disease: Effect of low protein diet and repletion with B vitamins.
|
Kidney Int
|
2005
|
0.81
|
|
186
|
Role of adipose tissue in determining muscle mass in patients with chronic kidney disease.
|
J Ren Nutr
|
2007
|
0.80
|
|
187
|
The Kidney Disease Improving Global Outcomes (KDIGO) guideline update for chronic kidney disease: evolution not revolution.
|
Clin Chem
|
2013
|
0.80
|
|
188
|
Factors associated with lipoprotein(a) in chronic kidney disease.
|
Am J Kidney Dis
|
2005
|
0.80
|
|
189
|
Nephrotic syndrome in diabetic kidney disease: an evaluation and update of the definition.
|
Am J Kidney Dis
|
2009
|
0.80
|
|
190
|
Which antihypertensive agents in chronic kidney disease?
|
Ann Intern Med
|
2006
|
0.80
|
|
191
|
Plasma total homocysteine levels among patients undergoing nocturnal versus standard hemodialysis.
|
J Am Soc Nephrol
|
2002
|
0.79
|
|
192
|
Aortic stiffness and kidney disease in an elderly population.
|
Am J Nephrol
|
2015
|
0.79
|
|
193
|
B-Type Natriuretic Peptide and Cardiac Troponin I Are Associated With Adverse Outcomes in Stable Kidney Transplant Recipients.
|
Transplantation
|
2016
|
0.78
|
|
194
|
Lipoprotein(a) and prevalent cardiovascular disease in a dialysis population: The Choices for Healthy Outcomes in Caring for ESRD (CHOICE) study.
|
Am J Kidney Dis
|
2003
|
0.78
|
|
195
|
Dialysis membrane and modality in acute renal failure: understanding discordant meta-analyses.
|
Semin Dial
|
2003
|
0.78
|
|
196
|
The challenges of the next 5 years.
|
Am J Kidney Dis
|
2007
|
0.78
|
|
197
|
Prevalence of ICD-9-CM codes for chronic kidney disease in individuals with cardiovascular disease risk factors.
|
J Nephrol
|
2009
|
0.77
|
|
198
|
mTOR inhibitors and autosomal dominant polycystic kidney disease.
|
N Engl J Med
|
2011
|
0.77
|
|
199
|
A decade after the KDOQI CKD guidelines.
|
Am J Kidney Dis
|
2012
|
0.77
|
|
200
|
How can the cardiac death rate be reduced in dialysis patients?
|
Semin Dial
|
2002
|
0.76
|
|
201
|
A stable definition of chronic kidney disease improves knowledge and patient care.
|
BMJ
|
2013
|
0.76
|
|
202
|
An editorial update: what level of blood pressure control in chronic kidney disease?
|
Ann Intern Med
|
2005
|
0.76
|
|
203
|
Influence of urine creatinine concentrations on the relation of albumin-creatinine ratio with cardiovascular disease events: the Multi-Ethnic Study of Atherosclerosis (MESA).
|
Am J Kidney Dis
|
2013
|
0.76
|
|
204
|
Fibroblast growth factor 23 and CKD prognosis.
|
Am J Kidney Dis
|
2011
|
0.75
|
|
205
|
Improving practice: reporting quality improvement activities.
|
Am J Kidney Dis
|
2007
|
0.75
|
|
206
|
Cognitive dysfunction and depression in adult kidney transplant recipients: baseline findings from the FAVORIT Ancillary Cognitive Trial (FACT).
|
J Ren Nutr
|
2011
|
0.75
|
|
207
|
Staying put, but not standing still.
|
Am J Kidney Dis
|
2012
|
0.75
|
|
208
|
Chronic kidney disease: common, harmful and treatable--World Kidney Day 2007.
|
Pediatr Nephrol
|
2007
|
0.75
|
|
209
|
KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors.
|
Transplantation
|
2017
|
0.75
|
|
210
|
Summary of Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors.
|
Transplantation
|
2017
|
0.75
|
|
211
|
Homocysteine, cysteine, and B vitamins as predictors of kidney disease progression.
|
Am J Kidney Dis
|
2002
|
0.75
|